Cefaly

Last updated: April 15, 2024

Pierre Rigaux, CEO
Pierre Rigaux, CEO
Country: UK | Add Funding

Website: http://www.cefaly.com

Cefaly offers the best safety efficacy ratio compared to current anti-migraine oral medication. It is the first line treatment for patients having frequent migraine attacks. Cefaly enables the use of medicines to be significantly reduced and the sufferer's quality of life to be markedly improved. It is the solution for most of migraineurs. Cefaly bears the CE Medical mark, is certified to the ISO Medical standard.